The IC50 for lymphocytes was ten-fold higher than that for AML; that is, lymphocytes were more resistant to NK-1R antagonists than AML cells and the damage induced by aprepitant in cancer cells was higher than that exerted in non-cancer cells (Table 2) [21]. The gene discussed is TACR1; the disease is cancer.